G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 102 filers reported holding G1 THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $62,562 | -35.2% | 43,446 | +12.0% | 0.00% | – |
| Q2 2023 | $96,610 | -10.8% | 38,799 | -4.0% | 0.00% | – |
| Q1 2023 | $108,339 | -54.8% | 40,425 | -8.4% | 0.00% | – |
| Q4 2022 | $239,724 | -63.1% | 44,148 | -15.1% | 0.00% | -100.0% |
| Q3 2022 | $649,000 | +153.5% | 51,983 | +0.2% | 0.00% | 0.0% |
| Q2 2022 | $256,000 | -37.3% | 51,863 | -3.3% | 0.00% | 0.0% |
| Q1 2022 | $408,000 | -20.5% | 53,625 | +6.7% | 0.00% | 0.0% |
| Q4 2021 | $513,000 | -7.4% | 50,242 | +21.7% | 0.00% | 0.0% |
| Q3 2021 | $554,000 | -37.2% | 41,293 | +2.7% | 0.00% | -50.0% |
| Q2 2021 | $882,000 | -9.7% | 40,220 | -0.9% | 0.00% | 0.0% |
| Q1 2021 | $977,000 | +37.4% | 40,599 | +2.7% | 0.00% | 0.0% |
| Q4 2020 | $711,000 | +19.3% | 39,513 | -23.5% | 0.00% | 0.0% |
| Q3 2020 | $596,000 | -32.0% | 51,620 | +42.9% | 0.00% | -33.3% |
| Q2 2020 | $876,000 | – | 36,122 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 120,000 | $172,800 | 0.15% |
| DENALI ADVISORS LLC | 148,800 | $214,272 | 0.08% |
| XTX Topco Ltd | 296,601 | $427,105 | 0.07% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 234,000 | $336,960 | 0.06% |
| LEVEL FOUR ADVISORY SERVICES, LLC | 183,400 | $264,096 | 0.02% |
| Curi Wealth Management, LLC | 70,742 | $101,869 | 0.02% |
| FRANKLIN STREET ADVISORS INC /NC | 83,400 | $120 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 140,000 | $201,600 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 573,256 | $825,489 | 0.01% |
| ALGERT GLOBAL LLC | 68,100 | $98 | 0.01% |